Wlodzimierz Stepkowski
Directeur/Membre du Conseil chez CANNABIS POLAND S.A.
Profil
Wlodzimierz Stepkowski is currently a Consultant-Information Technology at Erne Ventures SA, a Member-Supervisory Board at Hemp & Health SA, Polska Grupa Militarna SA, Cannabis Poland SA, Telehorse Sp zoo, and a Member-Supervisory Board at Super Liquid SA. He was previously a Member-Management Board at W3 Spzoo from 2010 to 2021.
Postes actifs de Wlodzimierz Stepkowski
Sociétés | Poste | Début |
---|---|---|
CANNABIS POLAND S.A. | Directeur/Membre du Conseil | - |
GARIN S.A. | Corporate Officer/Principal | 01/04/2015 |
ERNE VENTURES SA | Corporate Officer/Principal | 01/04/2015 |
POLSKA GRUPA MILITARNA SPÓLKA AKCYJNA | Directeur/Membre du Conseil | - |
HEMP & HEALTH S.A. | Directeur/Membre du Conseil | - |
Telehorse Sp zoo
Telehorse Sp zoo Packaged SoftwareTechnology Services Telehorse Sp zoo engages in the design of software. The company was founded on June 18, 2013 and is headquartered in Warsaw, Poland. | Directeur/Membre du Conseil | - |
Super Liquid SA | Directeur/Membre du Conseil | 01/01/2017 |
Anciens postes connus de Wlodzimierz Stepkowski
Sociétés | Poste | Fin |
---|
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 4 |
---|---|
CANNABIS POLAND S.A. | Health Technology |
GARIN S.A. | Consumer Durables |
POLSKA GRUPA MILITARNA SPÓLKA AKCYJNA | Technology Services |
HEMP & HEALTH S.A. | Commercial Services |
Entreprise privées | 3 |
---|---|
Telehorse Sp zoo
Telehorse Sp zoo Packaged SoftwareTechnology Services Telehorse Sp zoo engages in the design of software. The company was founded on June 18, 2013 and is headquartered in Warsaw, Poland. | Technology Services |
Erne Ventures SA
Erne Ventures SA Specialty StoresRetail Trade Erne Ventures SA is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; RX-5902 or Supinoxin for metastatic triple negative breast cancer; and RX-0201 or Archexin for renal cell carcinoma, glioblastoma, ovarian, stomach, and pancreatic cancer. It also develops nano-based drug delivery systems. The company was founded by Arkadiusz Stefan Kuich in September 2007 and is headquartered in Warszawa, Poland. | Retail Trade |
Super Liquid SA |